XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Total RadNet, Inc.'s Equity
Common Stock
Common Stock
Equity Incentive Plan
Common Stock
DeepHealth, Inc.
Additional Paid-In Capital
Accumulated Other Comprehensive income (loss)
Accumulated Deficit
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2023     67,956,318            
Beginning balance at Dec. 31, 2023 $ 813,359 $ 630,695 $ 7     $ 722,750 $ (12,484) $ (79,578) $ 182,664
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of options (in shares)     60,605            
Issuance of common stock upon exercise of options 367 367       367      
Issuance of common stock under the equity compensation plan (in shares)       666,962 9,377        
Stock-based compensation expense 21,406 21,406       21,406      
Issuance of common stock, net of issuance costs (in shares)     5,232,500            
Issuance of common stock, net of issuance costs 218,385 218,385 $ 0     218,385      
Issuance of common stock in connection with acquisitions (in shares)     95,019            
Issuance of common stock in connection with acquisitions 4,607 4,607       4,607      
Forfeiture of restricted stock and share cancellation (in shares)     (44,497)            
Forfeiture of restricted stock and share cancellation (38) (38)       (38)      
Sale of economic interests in majority owned subsidiary, net of taxes 16,917               16,917
Distributions paid to noncontrolling interests (2,423)               (2,423)
Contributions from noncontrolling interests 11,802 11,802       11,802      
Change in cumulative foreign currency translation adjustment 2,399 2,399         2,399    
Change in fair value of cash flow hedge from prior periods reclassified to earnings 8,242 8,242         8,242    
Net (loss) income 24,611 (2,552)           (2,552) 27,163
Ending balance (in shares) at Sep. 30, 2024     73,976,284            
Ending balance at Sep. 30, 2024 1,119,634 895,313 $ 7     979,279 (1,843) (82,130) 224,321
Beginning balance (in shares) at Jun. 30, 2024     73,968,042            
Beginning balance at Jun. 30, 2024 1,092,840 880,966 $ 7     974,355 (8,057) (85,339) 211,874
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock under the equity compensation plan (in shares)       9,075          
Stock-based compensation expense 4,727 4,727       4,727      
Forfeiture of restricted stock and share cancellation (in shares)     (833)            
Forfeiture of restricted stock and share cancellation (4) (4)       (4)      
Sale of economic interests in majority owned subsidiary, net of taxes 3,400               3,400
Contributions from noncontrolling interests 201 201       201      
Change in cumulative foreign currency translation adjustment 5,228 5,228         5,228    
Change in fair value of cash flow hedge from prior periods reclassified to earnings 986 986         986    
Net (loss) income 12,256 3,209           3,209 9,047
Ending balance (in shares) at Sep. 30, 2024     73,976,284            
Ending balance at Sep. 30, 2024 $ 1,119,634 895,313 $ 7     979,279 (1,843) (82,130) 224,321
Beginning balance (in shares) at Dec. 31, 2024 74,036,993   74,036,993            
Beginning balance at Dec. 31, 2024 $ 1,133,410 902,308 $ 7     988,147 (9,061) (76,785) 231,102
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of options (in shares)     111,376            
Issuance of common stock upon exercise of options 2,259 2,259 $ 1     2,258      
Issuance of common stock under the equity compensation plan (in shares)       1,039,311 3,438        
Stock-based compensation expense 46,466 46,466       46,466      
Issuance of common stock in connection with acquisitions (in shares)     1,848,152            
Issuance of common stock in connection with acquisitions 110,721 110,721       110,721      
Forfeiture of restricted stock and share cancellation (in shares)     (7,116)            
Forfeiture of restricted stock and share cancellation (190) (190)       (190)      
Distributions paid to noncontrolling interests (3,313)               (3,313)
Contributions from noncontrolling interests 2,389               2,389
Change in cumulative foreign currency translation adjustment 12,758 12,758         12,758    
Change in fair value of cash flow hedge from prior periods reclassified to earnings 2,273 2,273         2,273    
Net (loss) income $ 7,186 (18,055)           (18,055) 25,241
Ending balance (in shares) at Sep. 30, 2025 77,032,154   77,032,154            
Ending balance at Sep. 30, 2025 $ 1,313,959 1,058,540 $ 8     1,147,402 5,970 (94,840) 255,419
Beginning balance (in shares) at Jun. 30, 2025     75,067,102            
Beginning balance at Jun. 30, 2025 1,179,261 932,314 $ 8     1,025,936 6,627 (100,257) 246,947
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of options (in shares)     49,080            
Issuance of common stock upon exercise of options 1,704 1,704       1,704      
Issuance of common stock under the equity compensation plan (in shares)       68,599          
Stock-based compensation expense 9,191 9,191       9,191      
Issuance of common stock in connection with acquisitions (in shares)     1,848,152            
Issuance of common stock in connection with acquisitions 110,721 110,721       110,721      
Forfeiture of restricted stock and share cancellation (in shares)     (779)            
Forfeiture of restricted stock and share cancellation (150) (150)       (150)      
Change in cumulative foreign currency translation adjustment (874) (874)         (874)    
Change in fair value of cash flow hedge from prior periods reclassified to earnings 217 217         217    
Net (loss) income $ 13,889 5,417           5,417 8,472
Ending balance (in shares) at Sep. 30, 2025 77,032,154   77,032,154            
Ending balance at Sep. 30, 2025 $ 1,313,959 $ 1,058,540 $ 8     $ 1,147,402 $ 5,970 $ (94,840) $ 255,419